Skip to main content
Erschienen in: Journal of General Internal Medicine 9/2021

15.09.2020 | Concise Research Report

Oral Anticoagulant Use in a Racial and Ethnically Diverse Population with Atrial Fibrillation

verfasst von: Ankur Srivastava, BA, Eric Sun, MD, Aliasakar Hasani, MD, John D. Fisher, MD, Kevin J. Ferrick, MD, Andrew K. Krumerman, MD

Erschienen in: Journal of General Internal Medicine | Ausgabe 9/2021

Einloggen, um Zugang zu erhalten

Excerpt

Warfarin is an established therapy to prevent ischemic stroke in patients with atrial fibrillation.1 Direct oral anticoagulants (DOACs) have emerged as alternative therapies due to favorable risk-benefit profiles compared with warfarin.1 Many patients with atrial fibrillation that meet guideline recommended criteria, especially Black and Hispanic patients, are not treated with anticoagulants.2 Several investigators have noted differences in oral anticoagulant treatment for atrial fibrillation in Black and Hispanic patients compared with their white counterparts.2, 3 However, a major shortcoming of these studies is the limited representation of patients of color. …
Literatur
1.
Zurück zum Zitat January CT, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart R. Circulation. 2019;140(2). January CT, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart R. Circulation. 2019;140(2).
2.
Zurück zum Zitat Bhave PD, et al. Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation. Heart Rhythm. 2015;12(7):1406-1412.CrossRefPubMed Bhave PD, et al. Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation. Heart Rhythm. 2015;12(7):1406-1412.CrossRefPubMed
3.
Zurück zum Zitat Essien UR, et al. Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation. JAMA Cardiol. 2018;3(12):1174.CrossRefPubMed Essien UR, et al. Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation. JAMA Cardiol. 2018;3(12):1174.CrossRefPubMed
4.
Zurück zum Zitat Sur NB, et al. Disparities and Temporal Trends in the Use of Anticoagulation in Patients With Ischemic Stroke and Atrial Fibrillation. Stroke. 2019;50(6):1452-1459.CrossRefPubMed Sur NB, et al. Disparities and Temporal Trends in the Use of Anticoagulation in Patients With Ischemic Stroke and Atrial Fibrillation. Stroke. 2019;50(6):1452-1459.CrossRefPubMed
5.
Zurück zum Zitat Manheimer ED, et al. Referral Patterns for Primary Prophylaxis Implantable Cardioverter Defibrillator Therapy for an Urban US Population. Am J Cardiol. 2015;116(8):1210-1212.CrossRef Manheimer ED, et al. Referral Patterns for Primary Prophylaxis Implantable Cardioverter Defibrillator Therapy for an Urban US Population. Am J Cardiol. 2015;116(8):1210-1212.CrossRef
6.
Zurück zum Zitat Dayoub EJ, et al. Evolution of Medicare Formulary Coverage Changes for Antithrombotic Therapies After Guideline Updates. Circulation. 2019;140(14):1227-1230.CrossRef Dayoub EJ, et al. Evolution of Medicare Formulary Coverage Changes for Antithrombotic Therapies After Guideline Updates. Circulation. 2019;140(14):1227-1230.CrossRef
Metadaten
Titel
Oral Anticoagulant Use in a Racial and Ethnically Diverse Population with Atrial Fibrillation
verfasst von
Ankur Srivastava, BA
Eric Sun, MD
Aliasakar Hasani, MD
John D. Fisher, MD
Kevin J. Ferrick, MD
Andrew K. Krumerman, MD
Publikationsdatum
15.09.2020
Verlag
Springer International Publishing
Erschienen in
Journal of General Internal Medicine / Ausgabe 9/2021
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-06184-4

Weitere Artikel der Ausgabe 9/2021

Journal of General Internal Medicine 9/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.